Larry Page

Dr. Larry Page led five investments in Ag Fund I and is a Board member or observer in four Lewis & Clark Ventures portfolio companies. Larry joined Lewis & Clark in 2016 after working at PierianDx, a start-up specializing in clinical bioinformatics, where he managed several facets of the business including on the laboratory and sales teams. He was also an Entrepreneur-in-Residence at the Nidus Partnership, and he served as Chief Technology Officer of Terra Biologics, a start-up working to commercialize cyanobacteria-based biofertilizers.

Larry enjoys serving as a Preliminary Judge at Arch Grants, as a member of the Selection Committee for Invest Midwest, and as a Young Friend of the Donald Danforth Plant Science Center. Larry received his PhD in Biochemistry from Washington University in St. Louis and a B.S. in Biochemistry from the University of Missouri-Columbia.